Target intelligence / Profile preview

SLC12A9 antisense RNA 1 (SLC12A9-AS1)

Target: SLC12A9-AS1
Molecular classification: Long non-coding RNA, Antisense RNA, Non-coding RNA

Overview

SLC12A9 antisense RNA 1 (SLC12A9-AS1) is a long non-coding RNA gene found in the human genome (chromosome 7:100830413-100852645, hg38), transcribed from the strand opposite SLC12A9. It is classified as an antisense RNA, meaning it is generated from the DNA strand complementary to a protein-coding gene and likely involved in modulating expression of its neighbor through RNA-based regulatory mechanisms, although its specific biological role and disease implications in humans remain unclear[2][4][6][7][9]. Like other antisense lncRNAs, it may influence gene expression and epigenetic modifications, but there is limited published functional or mechanistic data specific to SLC12A9-AS1.

Other names: RP11-126L15.4SLC12A9-AS1

Mechanism of action

None

Biological functions

Regulation of neighboring gene expression via RNA-based mechanisms (antisense RNAs often modulate transcription or splicing of sense gene partners)Likely involved in epigenetic regulation, as antisense lncRNAs are known to recruit modifiers such as DNMT1 for DNA methylation (by analogy with other antisense RNAs, see [1])

Disease associations

Unknown for SLC12A9-AS1 specifically. General roles for antisense RNAs include involvement in regulation of gene expression in cancers and other diseases[1][5][7].lncRNAs, especially antisense, are widely studied as putative biomarkers and regulatory players in various cancers, but SLC12A9-AS1 has no currently documented direct disease implication[2][5][7].

Beyond the preview

Go deeper on SLC12A9 antisense RNA 1 (SLC12A9-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC12A9 antisense RNA 1 (SLC12A9-AS1).

Explore the full profile